Freshly Printed - allow 7 days lead
Couldn't load pickup availability
Bladder Cancer
Diagnosis and Clinical Management
Seth P. Lerner (Edited by), S Lerner (Author), Mark P. Schoenberg (Edited by), Cora N. Sternberg (Edited by)
9781118674840, Wiley
Hardback, published 9 October 2015
448 pages
25.2 x 19.6 x 2.3 cm, 1.034 kg
Bladder Cancer: Diagnosis and Clinical Management is a 100% clinically-focused guide to bladder cancer, providing practical, modern and evidence-based guidance to the latest in diagnosis and management of the condition. It differs from other books in its complete clinical focus as opposed to a heavy analysis of pathogenesis or basic science. As a result, practicing urologists and oncologists in the clinical setting will find it an essential resource to consult. In addition to the latest in diagnostic tools and imaging methods, core focus is on the management of each form of cancer at its various stages with up to date genomic data and targeted therapies. Both drug therapies and the range of surgical options are covered, ensuring that this is the perfect tool for clinicians to consult when considering which type of management program is appropriate for each individual patient. A key addition is the final section dedicated to optimizing health care delivery, featuring chapters on highly topical issues such as quality of life, patient advocacy and surgical education. Full color throughout, and packed with excellent images, each chapter contains concise and didactic practical tips and tricks to enrich the reading experience, in addition to management algorithms and the very latest guidelines from the ASCO, AUA, ESMO and EAU concerning clinical management of bladder cancer.
List of contributors vii Preface xii Acknowledgments xiii Part I: Diagnosis and treatment of non-muscle-invasive bladder cancer 1 Pathology 3 2 Risk stratification of high]grade Ta CIS and T1 urothelial carcinoma of the bladder 18 3 Utility of urine biomarkers 26 4 Novel endoscopic techniques for the detection of bladder cancer 39 5 Transurethral resection of bladder tumors 51 6 Intravesical chemotherapy 64 7 Intravesical immunotherapy 76 8 HGT1 bladder cancer: Diagnosis and treatment 89 9 What to do when bacillus Calmette-Guérin fails 98 Part II: T2–4 10 Selection and perioperative management of patients undergoing radical cystectomy and urinary reconstruction 111 11 Radical cystectomy: Techniques and outcomes 127 12 Cystectomy in the female patient 144 13 Laparoscopic/robotic radical cystectomy and urinary diversion: Outcomes 156 14 Robotic assisted radical cystectomy and urinary diversion: Clinical trials 167 15 Role of extended lymphadenectomy 176 16 Management of the urethra in the cystectomy patient 184 17 The role of radical cystectomy in patients with unresectable or regionally metastatic urothelial carcinoma of the bladder 190 Part III: Primary bladder-sparing therapy 18 Radical transurethral resection 201 19 Partial cystectomy 212 20 Integrating chemotherapy and radiotherapy for bladder cancer 221 Part IV: Urinary tract reconstruction 21 Orthotopic neobladder 235 22 Continent cutaneous diversion 244 23 Non]continent urinary diversion 258 Part V: Treatment of regionally advanced and metastatic bladder cancer 24 Molecular determinants of chemotherapy response 273 25 Neoadjuvant chemotherapy in the treatment of muscle-invasive bladder cancer 284 26 Adjuvant chemotherapy for invasive bladder cancer 295 27 Treatment of metastatic bladder cancer 304 28 Treatment of poor risk patients 320 Part VI: Genomics and the current status of urothelial cancer 29 Molecular events in muscle]invasive bladder cancer development 329 30 Cancer stem cells and intrinsic subtypes in bladder cancer 342 31 Multi-targeted agents in the treatment of urothelial carcinoma 353 Part VII: Optimizing healthcare delivery 32 Patient navigation and cancer navigator programs 365 33 Impact of health services on compliance and outcomes 375 34 Quality of life and survivorship 384 35 Bladder cancer: Healthcare delivery and third party payers 395 36 Bladder cancer patient advocacy: Creating partnerships to advance patient care research and clinical trials 402 Index 409
Hikmat Al-Ahmadie and Donna E. Hansel
Tobias Klatte, Fred Witjes, Gary Steinberg, and Shahrokh F. Shariat
Derya Tilki and Alexandre R. Zlotta
Ayman Soubra, Joseph C. Liao, and Badrinath Konety
Jen-Jane Liu and Mark P. Schoenberg
Levent N. Türkeri, M.Guillaume Wientjes, and Jessie L.S. Au
Nilay M. Gandhi, Laura A. Bertrand, Donald L. Lamm, and Michael A. O’Donnell
J.M. Gaya, J. Palou, and Edward M. Messing
Massimiliano Spaliviero, Guido Dalbagni, and Matthew Nielsen
Robert S. Svatek and Alon Z. Weizer
Siamak Daneshmand and Seth P. Lerner
Ryan Werntz, Georgios Gakis, Theresa Koppie, and Arnulf Stenzl
Kristina Wittig, Kevin Chan, Mark Kawachi, and Timothy G. Wilson
George J.S. Kallingal, Angela B. Smith, Raj S. Pruthi, and Dipen J. Parekh
Eugene K. Cha, George N. Thalmann, and Bernard H. Bochner
Kamal S. Pohar and Norm D. Smith
Scott Delacroix Jr, Nathan Lawrentschuk, and Ashish M. Kamat
Eduardo Solsona and Harry W. Herr
Ahmed Haddad, Yair Lotan, and Arthur I. Sagalowsky
Lior Z. Braunstein, William U. Shipley, Nicholas D. James, Andrea B. Apolo, and Jason A. Efstathiou
Eila C. Skinner
Andreas Neisius and Joachim W. Thüroff
Michael Rink, Fredrik Liedberg, and Margit Fisch
Matthew I. Milowsky, Peter H. O’Donnell, Thomas W. Flaig, and Dan Theodorescu
David I. Quinn and Cora N. Sternberg
André P. Fay, Jeffrey J. Leow, and Joaquim Bellmunt
Gopa Iyer, Fabio Calabró, and Dean F. Bajorin
Maria De Santis and Matthew D. Galsky
Jonathan Rosenberg, William Y. Kim, Jaegil Kim, and David J. Kwiatkowski
Keith Syson Chan and David J. McConkey
Noah M. Hahn, Colin P.N. Dinney, and Guru Sonpavde
Scott M. Gilbert and Michael Porter
Heather Honoré Goltz, Marc A. Kowalkowski, G. John Chen, and David M. Latini
Nihal E. Mohamed and Cheryl T. Lee
Seth A. Strope and John L. Gore
Diane Zipursky Quale and Rick Bangs
Subject Areas: Other branches of medicine [MM]
